Blog

Read more+

Mindways White Paper

Feature Coming Soon
An increasing awareness of some of the shortcomings of DXA is leading to renewed interest in the use of QCT in screening patients for low bone density and osteoporotic fracture risk. Bone density measurement by QCT can avoid the problems associated with DXA measurement due to obesity, rapid weight loss or gain, aortic calcification, scoliosis and osteophytes at the spine. The isolated measurement of trabecular bone at the spine by QCT coupled with the excellent precision of MindwaysCT QCT Pro™ means high sensitivity to early BMD changes. In addition, QCT Pro™ measurement of BMD at the hip is made in a way that produces T-Score equivalent to a DXA scan. Find out more
The efficiency and workflow advantage of being able to measure bone density using QCT during the same session as pelvic or abdominal CT scan is being recognized by physicians around the world. QCT Pro™ enables the earliest detection of bone loss and therapeutic response in patients prone to rapid and significant bone loss as a result of prolonged use of steroids and other therapies. Because the images that QCT analysis requires are almost identical to standard abdominal or pelvic CT exams, densitometry may be performed at the same time with no further CT dose and no moving over to a separate DXA unit. Find out more

    Featured Documents

    Physician Briefing Flyer

    A Physician’s guide to QCT BMD Testing

    Reimbursement Guide for QCT

    CPT & ICD coding and Medicare guidance

    back to top